These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11821731)

  • 41. Hepatocyte function during experimental use of a bioartificial liver.
    Papadimitriou D; Arkadopoulos N; Kouskouni E; Tsarouxa N; Demesticha T; Kousi T; Drakopoulou M; Mitrou S; Vassileiou J; Katsorhis T; Patargias T
    Transplant Proc; 2004; 36(6):1741-3. PubMed ID: 15350467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in cell sources of hepatocytes for bioartificial liver.
    Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):594-605. PubMed ID: 23232630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel bioartificial liver containing small tissue fragments: efficiency in the treatment of acute hepatic failure induced by carbon tetrachloride in rats.
    Soloviev V; Hassan AN; Akatov V; Lezhnev E; Ghaffar TY; Ghaffar YA
    Int J Artif Organs; 2003 Aug; 26(8):735-42. PubMed ID: 14521171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs.
    Kawazoe Y; Eguchi S; Sugiyama N; Kamohara Y; Fujioka H; Kanematsu T
    World J Gastroenterol; 2006 Dec; 12(46):7503-7. PubMed ID: 17167841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.
    Shinoda M; Tilles AW; Wakabayashi G; Takayanagi A; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    Tissue Eng; 2006 May; 12(5):1313-23. PubMed ID: 16771644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs.
    Cuervas-Mons V; Colás A; Rivera JA; Prados E
    Transplantation; 2000 Feb; 69(3):337-44. PubMed ID: 10706039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Configuration of a new bioartificial liver support system and in vitro evaluation of its functions.
    Chen Z; Ding Y; Li G
    Ann Clin Lab Sci; 2005; 35(1):7-14. PubMed ID: 15830704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The development of a new bioartificial liver and its application in 12 acute liver failure patients.
    Ding YT; Qiu YD; Chen Z; Xu QX; Zhang HY; Tang Q; Yu DC
    World J Gastroenterol; 2003 Apr; 9(4):829-32. PubMed ID: 12679942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mild hypothermic preservation for transport purposes of the AMC bioartificial liver charged with porcine hepatocytes.
    Poyck PP; Hoekstra R; van Wijk AC; ten Bloemendaal L; Chamuleau RA; van Gulik TM
    Transplantation; 2005 Nov; 80(9):1153-60. PubMed ID: 16314779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Liver Int; 2013 Apr; 33(4):516-24. PubMed ID: 23387413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biological and non-biological elimination therapy of acute liver failure. Experimental study on large laboratory animal].
    Ryska M; Lásziková E; Pantoflícek T; Kieslichová E; Ryska O; Prazák J; Koblihová E; Skibová J
    Cas Lek Cesk; 2008; 147(7):367-75. PubMed ID: 18678095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats.
    Arkadopoulos N; Lilja H; Suh KS; Demetriou AA; Rozga J
    Hepatology; 1998 Nov; 28(5):1365-70. PubMed ID: 9794923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of a larger version of the hybrid artificial liver support system using a polyurethane foam/spheroid packed-bed module in a warm ischemic liver failure pig model for preclinical experiments.
    Yamashita Y; Shimada M; Tsujita E; Shirabe K; Ijima H; Nakazawa K; Sakiyama R; Fukuda J; Funatsu K; Sugimachi K
    Cell Transplant; 2003; 12(2):101-7. PubMed ID: 12797371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total hepatectomy model in pigs: revised method for vascular reconstruction using a rigid vascular prosthesis.
    Sosef MN; van Gulik TM
    Eur Surg Res; 2004; 36(1):8-12. PubMed ID: 14730217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes.
    Wang Y; Zheng Q; Sun Z; Wang C; Cen J; Zhang X; Jin Y; Wu B; Yan T; Wang Z; Gu Q; Lv X; Nan J; Wu Z; Sun W; Pan G; Zhang L; Hui L; Cai X
    Cell Stem Cell; 2023 May; 30(5):617-631.e8. PubMed ID: 37059100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure.
    Nibourg GA; Chamuleau RA; van der Hoeven TV; Maas MA; Ruiter AF; Lamers WH; Oude Elferink RP; van Gulik TM; Hoekstra R
    PLoS One; 2012; 7(6):e38778. PubMed ID: 22719943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
    Shinoda M; Tilles AW; Kobayashi N; Wakabayashi G; Takayanagi A; Totsugawa T; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Tanaka N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    J Surg Res; 2007 Jan; 137(1):130-40. PubMed ID: 17081566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver.
    Nibourg GA; Boer JD; van der Hoeven TV; Ackermans MT; van Gulik TM; Chamuleau RA; Hoekstra R
    Biotechnol Bioeng; 2012 Dec; 109(12):3182-8. PubMed ID: 22729831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioartificial liver attenuates intestinal mucosa injury and gut barrier dysfunction after major hepatectomy: Study in a porcine model.
    Nastos C; Kalimeris K; Papoutsidakis N; Defterevos G; Pafiti A; Kalogeropoulou E; Zerva L; Nomikos T; Papalois A; Kostopanagiotou G; Smyrniotis V; Arkadopoulos N
    Surgery; 2016 Jun; 159(6):1501-1510. PubMed ID: 26847802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.